Resistance to the Antitumor Agent Gallium Nitrate in Human Leukemic Cells Is Associated with Decreased Gallium/Iron Uptake, Increased Activity of Iron Regulatory Protein-1, and Decreased Ferritin Production*

(Received for publication, October 23, 1996, and in revised form, January 17, 1997)

Christopher R. Chitambar Dagger and Janine P. Wereley

From the Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

The mechanism of drug resistance to gallium nitrate is not known. Since gallium can be incorporated into ferritin, an iron storage protein that protects cells from iron toxicity, we investigated whether ferritin expression was altered in gallium-resistant (R) CCRF-CEM cells. We found that the ferritin content of R cells was decreased, while heavy chain ferritin mRNA levels and iron regulatory protein-1 (IRP-1) RNA binding activity were increased. IRP-1 protein levels were similar in gallium-sensitive (S) and R cells, indicating that R cells contain a greater proportion of IRP-1 in a high affinity mRNA binding state. 59Fe uptake and transferrin receptor expression were decreased in R cells. In both S and R cells, gallium inhibited cellular 59Fe uptake, increased ferritin mRNA and protein, and decreased IRP-1 binding activity. Gallium uptake by R cells was markedly diminished; however, the sensitivity of R cells to gallium could be restored by increasing their uptake of gallium with excess transferrin. Our results suggest that R cells have developed resistance to gallium by down-regulating their uptake of gallium. In parallel, iron uptake by R cells is also decreased, leading to changes in iron homeostasis. Furthermore, since gallium has divergent effects on iron uptake and ferritin synthesis, its action may also include a direct effect on ferritin mRNA induction and IRP-1 activity.


INTRODUCTION

Gallium nitrate, a group IIIa metal salt with antineoplastic activity (1), is currently undergoing evaluation as a chemotherapeutic agent. A number of clinical studies have shown gallium to be effective in the treatment of lymphoma and bladder cancer (2-4). Although gallium is in clinical use, information regarding its action at the cellular and molecular levels is largely incomplete. It has been known for some time that gallium resembles iron in certain respects. Gallium binds avidly to the iron transport protein Tf1 (5) and is incorporated into cells by Tf receptor-dependent and -independent transport systems (6-8). Furthermore, we have shown that gallium inhibits the growth of several leukemic cell lines by inhibiting cellular iron uptake and by blocking the activity of ribonucleotide reductase (9-11).

Iron taken up by cells is stored in ferritin, a high molecular weight protein composed of 24 subunits of H and L chains (12). Ferritin sequesters excess intracellular iron and protects cells from the toxicity of iron overload. An increase in the delivery of iron to cells therefore serves as a powerful stimulus for ferritin synthesis. It is now established that iron-dependent ferritin and transferrin receptor gene expression is regulated by the binding of two iron regulatory proteins (IRPs), IRP-1 and IRP-2, to sequences termed iron-responsive elements (IREs) present at the 5'-untranslated region of ferritin mRNA and the 3'-untranslated region of Tf receptor mRNA (13-17). In iron-depleted cells, IRPs bind with high affinity to the IREs, resulting in suppression of ferritin mRNA translation and stabilization of Tf receptor mRNA (increased Tf receptor synthesis). Conversely, under conditions of intracellular iron excess, IRPs are converted to low affinity forms that no longer bind IREs. As a result, ferritin synthesis proceeds unhindered in iron-repleted cells, and Tf receptor synthesis is down-regulated. The iron-induced decrease in IRP-1 binding activity occurs through a switch between apoprotein (high affinity) and [4Fe-4S] forms (low affinity) without changes in IRP-1 levels (18), whereas the decrease in IRP-2 binding activity is due to iron-induced IRP-2 proteolysis (19, 20). IREs are also present on the 5'-untranslated regions of erythroid 5-aminolevulinate synthase (21) and mitochondrial aconitase (22) and on mitochondrial succinate dehydrogenase subunit b in Drosophila melanogaster (23). In addition to iron, nitric oxide (24-26), oxidative stress (27, 28), and ascorbic acid (29) have also been shown to regulate IRP binding to the IREs (reviewed in Ref. 30).

Tumor cell resistance to antineoplastic agents is a major obstacle to the successful treatment of malignancy. Recently, we reported the development of a line of human leukemic CCRF-CEM cells resistant to the growth inhibitory effects of gallium nitrate (31). In the present investigation, we have attempted to advance our understanding of the basis for this drug resistance. Because gallium interacts with various steps in iron metabolism, we hypothesized that the development of gallium resistance may be associated with changes in the cellular handling of iron and iron proteins. Moreover, since gallium can be incorporated into ferritin (7, 32) and ferritin protects cells from iron toxicity, we questioned whether this protein might play a role in modulating the cytotoxicity of gallium. Our studies show that the development of gallium resistance is due to a down-regulation in the transport of gallium into cells and that iron transport is affected in parallel, resulting in changes in the regulation of ferritin gene expression.


EXPERIMENTAL PROCEDURES

Materials

Gallium nitrate was obtained from Alpha Products (Danvers, MA). Heparin, bovine serum albumin, MTT, Tf, and dithiothreitol were obtained from Sigma. RNase T1 was obtained from Boehringer Mannheim. Na125I, 59FeCl3, [32P]GTP, and [32P]dCTP were purchased from Amersham Corp. 59Fe-Tf was prepared as described by Bates and Schlabach (33), and 125I-Tf was prepared by the chloramine-T method (34).

Cells

Human T lymphoblastic leukemic CCRF-CEM cells (S cells) were obtained from American Type Tissue Collection (Rockville, MD) and were grown in RPMI 1640 medium supplemented with 10% fetal calf serum in an atmosphere of 6% CO2 at 37 °C. A clone of CCRF-CEM cells resistant to the growth inhibitory effects of gallium nitrate (R cells) was developed in our laboratory through a process of continuous exposure of these cells to stepwise increments of gallium nitrate over the course of several months. R cells were routinely cultured in medium containing 150 µM gallium nitrate. For experiments, cells grown to confluency were harvested, washed with complete medium to remove gallium nitrate, and then subcultured in fresh medium in the presence or absence of gallium nitrate. At specified times, cells were harvested and analyzed as described below.

Cell Proliferation Assay

The effect of gallium on the proliferation of S and R cells was determined by MTT assay as described by Mossman (35). Cells were plated at an initial density of 2 × 105 cells/ml in 96-well microwell plates and incubated for 72 h in the presence of 0-1000 µM gallium nitrate. At the end of the incubation, 10 µl of MTT (5 mg/ml stock solution) was added to each well, and the cells were incubated at 37 °C for an additional 4 h. Cells were then solubilized by the addition of 100 µl of 0.04 N HCl in isopropyl alcohol to each well, and the absorbance of each well was determined spectrophotometrically at a dual wavelength of 570/630 nm using an EL 310 microplate auto-reader (Biotech Instruments, Winooski, VT). The effect of gallium nitrate on cell proliferation was determined by comparing the absorbance of the wells containing gallium nitrate with that of wells in which the drug was omitted. In some experiments, cell number was determined by directly counting cells using a hemocytometer.

cDNA Probes and Antiserum

cDNAs for rat L and H ferritin cloned into pGEM4Z and pSP65 vectors (Promega, Madison, WI), respectively, and rabbit antiserum to IRP-1 were generously provided by Richard Eisenstein and have been previously described (36). cDNAs for L and H ferritin were excised from the plasmids with PstI and EcoRI, respectively, and were 32P-labeled using a RadPrime DNA labeling system from Life Technologies, Inc. Human beta -actin cDNA probe was obtained from CLONTECH (Palo Alto, CA). 32P-Labeled IRE mRNA for the RNA band-shift assay was prepared, using as a template, a 1000-base pair rat L ferritin pseudogene that contains the conserved IRE sequence. The plasmid (p66-L gene) containing this insert (generously provided by Elizabeth Leibold) (13) was linearized with SmaI (Life Technologies, Inc.) and used for in vitro transcription of IRE mRNA. Transcription was carried out with Sp6 RNA polymerase using a Riboprobe transcription system from Promega.

Measurement of Cellular Ferritin

Ferritin in S and R CCRF-CEM cells was measured before and after a 24-h incubation in fresh medium. Cells were harvested; washed with 10 mM KPO4, pH 7.4, 150 mM NaCl buffer (PBS); and disrupted by sonication. Cellular debris was removed by centrifugation (30,000 × g for 30 min), and the cytoplasmic fraction (supernatant) was assayed for protein content using a Pierce BCA protein assay and for total ferritin using a Bio-Rad Quantimune ferritin assay. The ferritin content is expressed as ng/mg of protein.

RNA Isolation and Northern Blotting

Total cellular RNA was isolated from S and R cells by a modification of the method of Chomczynski and Sacchi (37) using RNAzol (Tel-Test Inc., Friendswood, TX) according to the manufacturer's recommendations. The integrity of the RNA was verified by agarose gel electrophoresis. Twenty micrograms of RNA from each preparation was electrophoresed on a 1% agarose gel containing 2.2 M formaldehyde and transferred to Nytran membranes (Schleicher & Schuell) using the capillary-blotting method. H and L ferritin and beta -actin mRNA were detected by sequential hybridization of the membranes to the corresponding 32P-labeled cDNA probes (1.2 × 106 cpm/ml) using QuickHyb hybridization solution (Stratagene, La Jolla, CA) according to the manufacturer's recommendations. Autoradiography of the membranes was carried out by exposing the membranes to XAR-5 film (Eastman Kodak Co.) with intensifying screens at -70 °C for 24-48 h. For quantitation of band intensities, the autoradiograph was scanned on an AMBIS optical imaging system. The band intensities obtained with 32P-labeled beta -actin were used to monitor for equal loading of RNA on the gels and to normalize the results obtained with hybridization using 32P-labeled L and H ferritin cDNA probes.

RNA Band-shift Assay

The binding of IRP-1 to ferritin IRE mRNA was examined by an RNA band-shift assay as described by Leibold and Munro (13). For preparation of cytoplasmic extracts, S and R cells were incubated for 24 h in fresh medium with or without gallium. Cells were then washed by centrifugation with PBS and were lysed in 20 mM HEPES, pH 7.6, containing 5% glycerol, 0.5 mM EDTA, 25 mM KCl, 1 mM dithiothreitol, 1% Nonidet P-40, and 1 mM phenylmethylsulfonyl fluoride. Cell lysates were centrifuged at 30,000 × g for 30 min, and the protein content of the supernatant was measured. For the band-shift assay, 40 µg of cytoplasmic extract from cells was incubated with 200,000 cpm of 32P-labeled IRE mRNA in binding buffer containing 10 mM HEPES, pH 7.6, 3 mM MgCl2, 40 mM KCl, 5% glycerol, and 1 mM dithiothreitol. To specifically identify IRP-1 binding to the IRE, incubation conditions were as described above, except that cytoplasmic extracts were incubated in binding buffer with 5 µl of antiserum to IRP-1 for 1 h at 4 °C prior to the addition of 32P-labeled IRE mRNA. After a 30-min incubation at room temperature, 1 unit of RNase T1 was added to the reaction mixture, and incubation was continued for an additional 10 min. Heparin (5 mg/ml) was then added to the reaction, and incubation was continued for another 10 min at room temperature. The mixture was resolved on a 5% nondenaturing polyacrylamide gel, and autoradiography of the gel was performed at -70 °C. For quantitation of band intensities, the autoradiograph was scanned on an AMBIS optical imaging system.

Western Blotting

S and R cells were incubated for 24 h in fresh medium containing 0-250 µM gallium nitrate. Approximately 5 × 107 cells were harvested; washed twice with ice-cold 10 mM Tris, pH 7.6, 150 mM NaCl buffer; and then resuspended in 150-500 µl of the same buffer. Phenylmethylsulfonyl fluoride (final concentration of 1 mM) was added to the cell suspension, and the cells were disrupted by sonication. The cell lysate was then centrifuged at 30,000 × g for 45 min at 4 °C, and the supernatant was assayed for protein content and used for Western blotting to detect IRP-1. SDS-polyacrylamide gel electrophoresis of the samples was performed according to the method of Laemmli (38), and proteins were transferred from the gel onto a nitrocellulose membrane as described by Towbin et al. (39) using a Transblot system (Bio-Rad). Membranes were incubated in 50 mM Tris, pH 7.5, 150 mM NaCl buffer (TS buffer) containing 2.5% bovine serum albumin for 1 h at room temperature, followed by a 90-min incubation in the same buffer containing rabbit antiserum against IRP-1 (1:1000 dilution). Following sequential washes in TS buffer and in TS buffer containing 0.05% Triton X-100 (TST), membranes were incubated for an additional 90 min at room temperature in TS buffer/bovine serum albumin containing 125I-protein A (200,000 cpm/ml). The membranes were finally washed in TS and TST buffers, and autoradiography of the membranes was carried out at -70 °C.

59Fe Uptake Studies

S and R cells were washed twice with medium and replated (0.5 × 106 cells/ml) in 1-ml 24-well plates in fresh medium with or without 150 µM gallium nitrate. 59Fe-Tf (6 µg of Tf, 10,000 cpm of 59Fe) was added to each well, and incubation was continued for 24 h. Following this, cell counts were determined, and the cells were removed from the wells and washed twice with ice-cold PBS. 59Fe cpm in the cell pellet was counted using a Wallac Compugamma gamma -counter. In addition to measuring 59Fe uptake by R cells that had been continuously grown in gallium-containing culture medium, 59Fe uptake by R cells was also determined after these cells had been washed to remove gallium and cultured for 72 h in culture medium without additives.

Gallium Uptake Studies

To measure the cellular uptake of gallium, cells were plated in triplicate in fresh medium (5 × 105 cells/ml) in 1-ml multiwell plates. Gallium nitrate (100-1000 µM) containing 67Ga as a tracer (1 µCi of 67Ga/1 mM gallium nitrate) was added to wells at the onset of incubation. After 48 and 72 h of incubation, cell counts were determined, and the cells were harvested and washed by centrifugation with PBS. 67Ga radioactivity in the cell pellet was counted in a Wallac Compugamma gamma -counter, and the amount 67Ga incorporated per 106 cells was determined.

125I-Tf Binding Studies

Cell-surface Tf receptor density was determined by 125I-Tf binding to intact cells. Confluent S and R CCRF-CEM cells were washed and reincubated in fresh medium without gallium nitrate. After 24 and 48 h of incubation, cells were harvested, washed with ice-cold PBS containing 0.1% bovine serum albumin, and assayed for 125I-Tf binding at 37 °C as described previously (40). In separate experiments, R cells that had been grown for 8 weeks in the absence of gallium were also assayed for 125I-Tf binding. Maximal Tf binding and Tf receptor affinity for Tf were determined according to the method of Scatchard (41).


RESULTS

Demonstration of Resistance to Growth Inhibition by Gallium Nitrate

As previously reported (31), a gallium-resistant CCRF-CEM cell line was developed by us. To confirm that these cells continued to display a gallium-resistant phenotype, their growth in the presence of gallium was compared with that of S cells (the parent cell line). Based on the concentration of gallium required to inhibit cell growth by 50%, R cells were ~8-fold more resistant to growth inhibition by gallium nitrate than S cells (Fig. 1).


Fig. 1. Effect of gallium nitrate on the growth of gallium-sensitive and -resistant CCRF-CEM cells. Cells were plated at a density of 2 × 105 cells/ml in the presence of increasing concentrations of gallium nitrate. Cell growth was determined after 72 h of incubation.
[View Larger Version of this Image (22K GIF file)]

Ferritin Is Decreased in Gallium-resistant CCRF-CEM Cells

Since prior studies have shown that gallium can be incorporated into ferritin (7, 32), we first investigated whether gallium resistance could be due to an increase in ferritin content, leading to sequestration of intracellular gallium. S and R cells were therefore analyzed for ferritin content. However, as shown in Table I, R cells were found to contain significantly less ferritin than S cells. At stationary phase (confluency, 0 h), the ferritin content of R cells was ~27% that of S cells. Following 24 h of growth in fresh medium without gallium nitrate, ferritin in both S and R cells decreased significantly; however, the decrease in ferritin was greater in R cells than in S cells. As a result, after 24 h, the amount of ferritin in R cells was only 9% that in S cells. When the 24-h incubation was carried out in the presence of a concentration of gallium nitrate that did not inhibit cell growth, the amount of ferritin in R cells decreased, but remained almost 2-fold higher than that in cells incubated without gallium nitrate. In contrast, in the presence of gallium nitrate, the ferritin content of S cells increased rather than decreased over this period (Table I).

Table I. Effect of gallium on cellular ferritin content

Gallium-sensitive and -resistant CCRF-CEM cells were analyzed for ferritin at stationary phase (0 h) and after 24 h of growth in fresh medium with or without additives. Data shown represent means ± S.E. of three to five separate experiments. Gallium-sensitive and -resistant CCRF-CEM cells were analyzed for ferritin at stationary phase (0 h) and after 24 h of growth in fresh medium with or without additives. Data shown represent means ± S.E. of three to five separate experiments.
Cells Ferritin
0 h 24 h
No additive +Gaa +FAC

ng/mg protein
Sensitive 92  ± 5.9 64  ± 10.3 119  ± 46 249  ± 32
Resistant 25  ± 1.2 6  ± 1.2 11  ± 3.3 35  ± 3.9

a +Ga, 150 µM gallium nitrate; +FAC, 50 µM ferric ammonium citrate.

To determine whether R cells were able to increase their production of ferritin in response to iron, cells were incubated with ferric ammonium citrate for 24 h. Table I shows that 50 µM ferric ammonium citrate produced 2.7- and 1.4-fold increases in ferritin in S and R cells, respectively.

Ferritin mRNA Levels in Gallium-sensitive and -resistant Cells

Steady-state H and L ferritin mRNA levels in S and R cells were examined to determine whether the differences in ferritin content were due to changes in mRNA. Northern blot analysis of mRNA, however, revealed that although R cells had markedly less ferritin protein than S cells, they displayed increased levels of H ferritin mRNA and equivalent levels of L ferritin mRNA (Fig. 2, upper panel, compare the band intensities of S and R cells incubated without gallium). Unexpectedly, incubation of cells with gallium induced a marked increased in H and L ferritin mRNAs in both R and S cells (Fig. 2, upper panel). As illustrated further in the lower panel of Fig. 2, H ferritin mRNA levels in S cells increased in a dose-dependent manner following exposure to increasing concentrations of gallium. S cells incubated with 50 and 150 µM gallium nitrate displayed 1.6- and 3.7-fold increases in H ferritin mRNA, respectively, relative to cells grown without gallium.


Fig. 2. Northern blot analysis. Upper panel, comparison of H and L ferritin mRNAs in gallium-sensitive and -resistant CCRF-CEM cells. S and R cells were incubated for 24 h in the presence or absence of gallium nitrate. Total cellular RNA was isolated, electrophoresed on a formaldehyde-agarose (1%) gel, and transferred to a membrane. The membrane was hybridized sequentially to 32P-labeled cDNAs for H ferritin, L ferritin, and beta -actin. The membrane was stripped of the respective 32P-labeled cDNA probes between each hybridization. Data shown are from a single membrane and are representative of six separate experiments. Lower panel, effect of gallium on H ferritin mRNA levels in gallium-sensitive cells. Cells were incubated for 24 h in the presence or absence of gallium nitrate. Total cellular RNA was isolated, electrophoresed on a formaldehyde-agarose (1%) gel, and transferred to a membrane. The membrane was hybridized to 32P-labeled cDNA for H ferritin. Equal RNA loading in each well was confirmed by hybridization of the membrane to 32P-labeled beta -actin (not shown). Data shown are representative of three separate experiments.
[View Larger Version of this Image (73K GIF file)]

IRP-1 Activity Is Increased in Gallium-resistant Cells

The above experiments suggested that although H and L ferritin mRNA levels were increased in R cells, their translation was inhibited. Since ferritin synthesis is regulated at the translational level by the binding of IRPs to H and L ferritin mRNAs, IRP binding activity in S and R cells was examined by band-shift assay. As shown in Fig. 3, IRP mRNA binding was increased ~2.4-fold in R cells incubated for 24 h in the absence of gallium (compare lanes and 4 with lanes 1 and 2). Antibody to IRP-1 produced a supershift in these bands (lanes 9 and 10), indicating that they specifically represent IRP-1 binding to ferritin mRNA. Fig. 3 also shows that in the presence of gallium, IRP activity in both S and R cells was decreased; however, it still remained greater in R cells than in S cells.


Fig. 3. IRP binding activity in gallium-sensitive and -resistant cells. Cells were analyzed for IRP-1 mRNA binding activity after 24 h of incubation with or without 250 µM gallium as detailed under "Experimental Procedures." Upper panel, band-shift assay. Lanes 1 and 2, S cells incubated without gallium; lanes 3 and 4, R cells incubated without gallium; lanes 5 and 6, S cells incubated with gallium; lanes 7 and 8, R cells incubated with gallium; lane 9, S cells incubated without gallium and supershifted with IRP-1 antibody; lane 10, R cells incubated without gallium and supershifted with IRP-1 antibody. Lower panel, relative IRP binding activity. Band intensities of lanes 1-8 were determined by densitometry. Bars represent the mean band intensities of duplicate lanes and are relative to S cells incubated without gallium.
[View Larger Version of this Image (51K GIF file)]

To exclude the possibility that the differences in IRP-1 activity in R cells were due to changes in the amount of IRP-1 protein, cells were analyzed by Western blotting after a 24-h incubation with increasing concentrations of gallium nitrate (0-250 µM). In three separate experiments, S and R cells were found to contain comparable amounts of IRP-1, which did not change significantly following exposure of cells to gallium (data not shown).

Iron Uptake by Gallium-sensitive and -resistant CCRF-CEM Cells

Since prior studies showed that gallium inhibits the cellular uptake of iron (9), we investigated whether the differences in ferritin content between S and R cells could be explained by an effect of gallium on iron transport into cells. Cells were therefore examined for 59Fe uptake in the presence and absence of gallium nitrate. As shown in Fig. 4, 59Fe uptake by S cells was decreased by ~31% in the presence of 150 µM gallium nitrate. In contrast, 59Fe uptake by R cells was markedly decreased even in the absence of gallium nitrate and was ~60% lower than that by S cells. With the addition of gallium nitrate to the incubation, 59Fe uptake by R cells was decreased further, albeit to a lesser extent than that seen with S cells.


Fig. 4. 59Fe uptake. S and R cells were washed with medium and plated (5 × 105 cells/ml) with (+) or without (-) 150 µM gallium nitrate. 59Fe-Tf was added at the onset of incubation, and 59Fe uptake by cells was determined after 24 h of growth. Resistant/R1 cells represent R cells that had been grown in fresh medium without gallium nitrate for 72 h prior to the 59Fe uptake study. Bars represent means ± S.E. (n = 3).
[View Larger Version of this Image (29K GIF file)]

Prior to being used in these experiments, R cells were washed extensively to remove gallium present in the stock cultures; however, to confirm that the decrease in iron uptake by R cells was not due to residual gallium in the system, 59Fe uptake studies were also performed using R cells that had washed, incubated for 3 days in fresh medium without gallium, and then washed again. 59Fe uptake by these cells (R1 cells) was identical to that seen with washed R cells taken directly from stock cultures (Fig. 4). Even after 12 days (three passages) of culture of R cells in gallium-free medium, 59Fe uptake by R cells remained only 40% that of S cells (data not shown). Hence, the decrease in iron incorporation into R cells was not a result of an inhibition of iron uptake by the presence of residual gallium.

Gallium Transport into Resistant Cells Is Decreased

To determine whether the mechanism of drug resistance to gallium involves changes in its transport into cells, gallium uptake by R cells was compared with that of S cells. To correlate gallium transport into cells with the cytotoxicity assays, gallium uptake by cells was examined after 48- and 72-h incubations in the presence of increasing concentrations of gallium nitrate with 67Ga as a tracer. When incubated with 100 µM gallium (a noncytotoxic concentration), both S and R cells incorporated similar amounts of gallium/cell over 48 and 72 h (Fig. 5). Incubation with higher concentrations of gallium nitrate resulted in increases in gallium uptake by both S and R cells; however, gallium incorporation into R cells was significantly lower and, in the presence of 1000 µM gallium nitrate, was only 34-36% that into S cells (Fig. 5).


Fig. 5. Uptake of gallium by gallium-resistant and -sensitive cells. Cells were plated at 0.5 × 106/ml in the presence of increasing concentrations of gallium nitrate containing 67Ga (1 µCi/1 mM gallium nitrate) as a tracer. Gallium uptake (67Ga) was determined after 48 h (upper panel) and 72 h (lower panel). Cell counts were performed simultaneously to determine the amount of 67Ga incorporated per 106 cells. Values shown represent the mean and range of an experiment performed in duplicate. Three separate experiments produced similar results.
[View Larger Version of this Image (22K GIF file)]

125I-Tf Binding Studies

125I-Tf binding to S and R cells was examined to determine whether the decrease in gallium and iron uptake by R cells could be explained on the basis of a decrease in Tf receptors. As shown in Fig. 6A, 125I-Tf binding to R cells was ~72 and 54% that of S cells after 24 and 48 h of incubation, respectively, in the absence of gallium. To examine whether this decrease in Tf receptors was related to a residual effect of exogenous gallium, 125I-Tf binding to R cells was measured again after 8 weeks of growth of these cells in medium without gallium. Drug resistance to gallium was retained even after growth of these cells in the absence of gallium (data not shown). Scatchard analysis of 125I-Tf binding to cell-surface Tf receptors (shown in Fig. 6B) revealed that maximal 125I-Tf binding to R cells was ~53% that of S cells at 48 h without a significant change in Tf receptor affinity for Tf (KD = 9.8 × 10-9 M for S cells and 6.71 × 10-9 M for R cells).


Fig. 6. 125I-Tf binding studies. A, S and R cells assayed for 125I-Tf binding at 37 °C after 24- and 48-h incubations in medium without gallium. Values shown are means of a binding study performed in duplicate and are representative of three separate assays. B, Scatchard analysis of 125I-Tf binding at 4 °C to cell-surface Tf receptors on S and R cells after growth of R cells for 8 weeks in the absence of gallium.
[View Larger Version of this Image (20K GIF file)]

Transferrin Increases Gallium Uptake by R Cells and Restores Sensitivity to Gallium

The above experiments show that R cells have a decrease in gallium uptake and changes in transferrin receptor number. Since Tf is known to enhance gallium uptake by cells (6, 7, 9), further experiments were performed to determine whether increasing the amount of exogenous Tf would enhance gallium uptake and increase its cytotoxicity in R cells. As shown in Fig. 7, the presence of 1 mg/ml transferrin resulted in a marked increase in the uptake of gallium by R cells (upper panel) and a progressive inhibition of cell proliferation (lower panel). When added to R cells incubated with 1000 µM gallium, Tf produced a 3.4-fold increase in gallium uptake and completely inhibited cell proliferation.


Fig. 7. Effect of transferrin on the uptake and cytotoxicity of gallium in resistant cells. Cells were plated at 0.5 × 106/ml in the presence of increasing concentrations of gallium nitrate containing 67Ga (1 µCi/1 mM gallium nitrate) as a tracer. Gallium uptake (67Ga) was determined after 72 h in the absence (upper panel, left) and presence (upper panel, right) of 1 mg/ml transferrin. Corresponding cell counts are also shown (lower panel).
[View Larger Version of this Image (28K GIF file)]


DISCUSSION

As an iron storage protein, ferritin plays an important role in protecting cells from the toxicity of excessive intracellular iron. In addition to sequestering iron, however, ferritin can also bind gallium (7, 32). This latter property of ferritin prompted us to initially investigate whether the development of drug resistance to gallium was associated with changes in ferritin gene expression. Our studies revealed that whereas ferritin mRNA levels were increased in R cells, ferritin protein content was markedly diminished. Further investigation demonstrated that IRP-1 RNA binding activity was increased, thus suggesting that the decrease in ferritin production in R cells was the result of a repression of ferritin mRNA translation. IRP-1 protein levels were equivalent in R and S cells, indicating that the increase in IRP-1 binding activity in R cells was due to a greater proportion of IRP-1 existing in a high affinity mRNA binding state. Since IRP/RNA interactions are directly influenced by changes in cellular iron, iron uptake studies were carried out that showed that 59Fe incorporation into R cells was <50% that into S cells even in the absence of gallium. Hence, it appears that the switch in IRP-1 from a low to a high affinity mRNA binding state in R cells is due to a down-regulation of iron uptake and a depletion of an intracellular iron "pool" responsible for influencing IRP binding activity.

Whereas the inhibitory effect of gallium on iron uptake by S and R CCRF-CEM cells was consistent with earlier results in other gallium-sensitive cell lines (9), an unexpected finding was that iron uptake by R cells was consistently less than that by S cells even after extended growth of R cells in the absence of gallium. Since earlier studies have shown that cells incorporate iron and gallium by similar Tf-dependent and -independent transport systems (6-8), we questioned whether the uptake of gallium by R cells was also decreased. Gallium uptake studies were therefore performed that showed that when challenged with increasing concentrations of gallium nitrate, R cells incorporated significantly less gallium than S cells. Hence, it appears that R cells have a decrease in the activity of a metal uptake transport system that affects both gallium and iron. This decrease in gallium uptake would serve to protect cells from the cytotoxicity of gallium, while the parallel decrease in iron uptake would lead to changes in intracellular iron homeostasis.

While the gallium uptake studies strongly suggest that the development of gallium resistance is primarily due to a down-regulation of gallium transport into cells, the specific transport mechanisms involved remain to be fully elucidated. One explanation for the decrease in gallium uptake is that the lower number of Tf receptors expressed on R cells during proliferation may serve to limit transferrin-mediated uptake of Tf-gallium complexes (formed by the binding of gallium to Tf in the culture medium). Alternatively, the decrease in gallium uptake by R cells may be secondary to a decrease in the activity of a transferrin-independent gallium/iron transport system. It is conceivable that both transport systems work in concert to decrease the uptake of gallium by R cells. Regardless of the membrane transport system involved, our studies indicate that the decrease in gallium uptake is central to the mechanism of drug resistance to gallium. Further evidence for this mechanism is provided by the demonstration that the sensitivity of R cells to gallium could be restored by increasing their uptake of gallium with excess Tf (Fig. 7). Increasing the amount of Tf favors the formation of Tf-gallium complexes and stimulates Tf receptor-mediated uptake of gallium, thereby overriding the basal decrease in gallium transport into R cells. Studies are in progress to elucidate how Tf-dependent and -independent gallium transport pathways are regulated in R cells and to determine their relative roles in gallium resistance.

Although the decrease in ferritin in R cells appears to be secondary to the decrease in iron uptake, the effect of gallium on ferritin gene expression appears to be complex. Since gallium inhibited iron uptake by both S and R cells, cells incubated with gallium would be expected to contain less ferritin than cells incubated without gallium. Instead, cells incubated with gallium contained more ferritin mRNA, lower IRP-1 binding activity, and more ferritin protein than cells incubated without this metal. These results suggest that gallium may affect ferritin expression through mechanisms that are independent of its inhibitory action on cellular iron uptake. Although there is no evidence that gallium interacts directly with IRP-1 to alter its mRNA binding activity, Cowley et al. (42) have reported the synthesis of a cubic gallium-sulfur cluster with gallium in place of iron. This raises the intriguing possibility that intracellular gallium may be capable of interacting with the iron-sulfur cluster of IRP-1 to produce a change in its affinity for the IREs. However, an alternative explanation for the gallium-induced increase in ferritin may be that intracellular gallium displaces iron from its binding to different ligands/macromolecules, thereby leading to an increase in an iron pool, which, in turn, produces a decrease in IRP activity and an increase in ferritin synthesis.

While a direct interaction of gallium with IRP-1 remains speculative at this time, our studies clearly demonstrate that gallium, in a dose-dependent manner, increases H ferritin mRNA and, to a lesser degree, L ferritin mRNA. The mechanism for this increase is unknown and is under investigation. Several studies have shown that ferritin gene expression can be induced by a number of stimuli that are unrelated to iron. Cytokines such as interleukin-1alpha , tumor necrosis factor-alpha , and interferon-gamma induce H ferritin mRNA transcription and increase H ferritin synthesis in cells (43, 44), whereas interleukin-1beta increases the synthesis of both H and L ferritin by increasing mRNA translation (45). More recently, thyroid hormone has been shown to increase ferritin synthesis by modulating the interaction between IRP and ferritin mRNA (46). Hence, it is conceivable that gallium may influence ferritin mRNA transcription and IRP activity through mechanisms that are independent of iron metabolism.

In conclusion, these studies are the first to show that the development of drug resistance to gallium involves a diminution in the transport of gallium into cells and that this alteration in gallium transport also affects iron transport and ferritin gene expression. Continued investigation of the interaction of gallium with biological systems may enhance our understanding of the mechanisms of its transport, cytotoxicity, and drug resistance and may allow us to increase its efficacy as an antineoplastic agent.


FOOTNOTES

*   This work was supported by United States Public Health Service Grant RO1 CA68028.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: Div. of Hematology/Oncology, Medical College of Wisconsin, 9200 W. Wisconsin Ave., Milwaukee, WI 53226. Tel.: 414-257-6868; Fax: 414-257-6971; E-mail: Chitambr{at}hemonc.mcw.edu.
1   The abbreviations used are: Tf, transferrin; H, heavy chain; L, light chain; IRP, iron regulatory protein; IRE, iron-responsive element; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; S cells, gallium-sensitive cells; R cells, gallium-resistant cells.

REFERENCES

  1. Foster, B. J., Clagett-Carr, K., Hoth, D., and Leyland-Jones, B. (1988) Cancer Treat. Rep. 70, 1311-1319
  2. Warrell, R. P., Jr., Coonley, C. J., Straus, D. J., and Young, C. W. (1983) Cancer (Phila.) 51, 1982-1987 [Medline] [Order article via Infotrieve]
  3. Keller, J., Bartolucci, A., Carpenter, J. T., Jr., and Feagler, J. (1986) Cancer Treat. Rep. 70, 1221-1223 [Medline] [Order article via Infotrieve]
  4. Seidman, A. D., Scher, H. I., Heinemann, M. H., Bajorin, D. F., Sternberg, C. N., Dershaw, D. D., Silverberg, M., and Bosl, G. J. (1991) Cancer (Phila.) 68, 2561-2565 [Medline] [Order article via Infotrieve]
  5. Harris, W. R., and Pecoraro, V. L. (1983) Biochemistry 22, 292-299 [Medline] [Order article via Infotrieve]
  6. Larson, S. M., Rasey, J. S., Allen, D. R., Nelson, N. J., Grunbaum, Z., Harp, G. D., and Williams, D. L. (1980) J. Natl. Cancer Inst. 64, 41-53 [Medline] [Order article via Infotrieve]
  7. Chitambar, C. R., and Zivkovic, Z. (1987) Cancer Res. 47, 3929-3934 [Abstract]
  8. Chitambar, C. R., and Sax, D. (1992) Blood 80, 505-511 [Abstract]
  9. Chitambar, C. R., and Seligman, P. A. (1986) J. Clin. Invest. 78, 1538-1546 [Medline] [Order article via Infotrieve]
  10. Chitambar, C. R., Matthaeus, W. G., Antholine, W. E., Graff, K., and O'Brien, W. J. (1988) Blood 72, 1930-1936 [Abstract]
  11. Chitambar, C. R., Narasimhan, J., Guy, J., Sem, D. S., and O'Brien, W. J. (1991) Cancer Res. 51, 6199-6201 [Abstract]
  12. Harrison, P. M., Andrews, S. C., Artymiuk, P. L., Ford, G. C., Lawson, D. M., Smith, J. M. A., Treffry, A., and White, J. L. (1990) in Iron Transport and Storage (Ponka, P., Schulman, H. M., and Woodworth, R. C., eds), pp. 81-101, CRC Press, Inc., Boca Raton, FL
  13. Leibold, E. A., and Munro, H. N. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2171-2175 [Abstract]
  14. Henderson, B. R., Seiser, C., and Kühn, L. C. (1993) J. Biol. Chem. 268, 27327-27334 [Abstract/Free Full Text]
  15. Samaniego, F., Chin, J., Iwai, K., Rouault, T. A., and Klausner, R. D. (1994) J. Biol. Chem. 269, 30904-30910 [Abstract/Free Full Text]
  16. Theil, E. C. (1994) Biochem. J. 304, 1-11 [Medline] [Order article via Infotrieve]
  17. Masciotti, D. P., Rup, D., and Thach, R. E. (1995) Annu. Rev. Nutr. 15, 239-261 [CrossRef][Medline] [Order article via Infotrieve]
  18. Tang, C. K., Chin, J., Harford, J. B., Klausner, R. D., and Rouault, T. A. (1992) J. Biol. Chem. 267, 24466-24470 [Abstract/Free Full Text]
  19. Guo, B., Yu, Y., and Leibold, E. A. (1994) J. Biol. Chem. 269, 24252-24260 [Abstract/Free Full Text]
  20. Guo, B., Phillips, J. D., Yu, Y., and Leibold, E. A. (1995) J. Biol. Chem. 270, 21645-21651 [Abstract/Free Full Text]
  21. Dandekar, T., Stripecke, R., Gray, N. K., Goosen, B., Constable, A., Johansson, H. E., and Hentze, M. W. (1991) EMBO J. 10, 1903-1909 [Abstract]
  22. Zheng, L., Kennedy, M. C., Blondin, G. A., Beinert, H., and Zalkin, H. (1992) Arch. Biochem. Biophys. 299, 356-360 [Medline] [Order article via Infotrieve]
  23. Kohler, S., Henderson, B. R., and Kühn, L. C. (1995) J. Biol. Chem. 270, 30781-30786 [Abstract/Free Full Text]
  24. Weiss, G., Goosen, B., Doppler, W., Fuchs, D., Pantopoulos, K., WernerFelmayer, G., Wachter, H., and Hentze, M. W. (1993) EMBO J. 12, 3651-3657 [Abstract]
  25. Drapier, J. C., Hirling, H., Wietzerbin, J., Kaldy, P., and Kuhn, L. C. (1993) EMBO J. 12, 3643-3649 [Abstract]
  26. Richardson, D. R., Neumannova, V., Nagy, E., and Ponka, P. (1995) Blood 86, 3211-3219 [Abstract/Free Full Text]
  27. Martins, E. A. L., Robalinho, R. L., and Meneghini, R. (1995) Arch. Biochem. Biophys. 316, 128-134 [CrossRef][Medline] [Order article via Infotrieve]
  28. Cairo, G., Tacchini, L., Pogliaghi, G., Anzon, E., Tomasi, A., and Bernelli-Zazzera, A. (1995) J. Biol. Chem. 270, 700-703 [Abstract/Free Full Text]
  29. Toth, I., and Bridges, K. R. (1995) J. Biol. Chem. 270, 19540-19544 [Abstract/Free Full Text]
  30. Hentze, M. W., and Kühn, L. C. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8175-8182 [Abstract/Free Full Text]
  31. Chitambar, C. R., Boon, P., and Wereley, J. P. (1996) Clin. Cancer Res. 2, 1009-1015 [Abstract]
  32. Hegge, F. N., Mahler, D. J., and Larson, S. M. (1977) J. Nucl. Med. 18, 937-939 [Abstract]
  33. Bates, G. W., and Schlabach, M. R. (1973) J. Biol. Chem. 248, 3228-3232 [Abstract/Free Full Text]
  34. Hunter, H. M., and Greenwood, F. C. (1962) Nature 194, 495-496
  35. Mossman, T. (1983) J. Immmunol. Methods 65, 55-63 [CrossRef][Medline] [Order article via Infotrieve]
  36. Eisenstein, R. S., Tuazon, P. T., Schalinske, K. L., Anderson, S. A., and Traugh, J. A. (1993) J. Biol. Chem. 268, 27363-27370 [Abstract/Free Full Text]
  37. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159 [CrossRef][Medline] [Order article via Infotrieve]
  38. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  39. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354 [Abstract]
  40. Chitambar, C. R., Massey, E. J., and Seligman, P. A. (1983) J. Clin. Invest. 72, 1314-1325 [Medline] [Order article via Infotrieve]
  41. Scatchard, G. (1949) Ann. N. Y. Acad. Sci. 51, 660-672
  42. Cowley, A. H., Jones, R. A., Harris, P. R., Atwood, D. A., Contreras, L., and Burek, C. J. (1991) Angew. Chem. Int. Ed. Engl. 30, 1143-1144
  43. Tsuji, Y., Miller, L. L., Miller, S. C., Torti, S. V., and Torti, F. M. (1991) J. Biol. Chem. 266, 7257-7261 [Abstract/Free Full Text]
  44. Fahmy, M., and Young, S. P. (1993) Biochem. J. 296, 175-181 [Medline] [Order article via Infotrieve]
  45. Rogers, J. T., Bridges, K. R., Durmowicz, G. P., Glass, J., Auron, P. E., and Munro, H. N. (1990) J. Biol. Chem. 265, 14572-14578 [Abstract/Free Full Text]
  46. Leedman, P. J., Stein, A. R., Chin, W. W., and Rogers, J. T. (1996) J. Biol. Chem. 271, 12017-12023 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.